Herz- und Diabeteszentrum, NRW
Bad Oeynhausen, North Rhine-Westphalia, 32545, Germany
Location status: Recruiting
NCT Number: NCT04882488
Aortic valve stenosis (AS) affects 2-7% of persons > 65 years, symptoms include: angina and dyspnea, dizziness and syncope. Coincidence of coronary artery disease (CAD), also presenting with angina and dyspnea, in patients with AS between 40 - 65% . Angina in AS caused by significant reduction of coronary flow reserve (CFR). CFR is the ratio of maximal flow increase in the coronary vessel bed during maximal hyperaemia (medically or exercise induced). FFR (fractional flow reserve) use in patients with AS potentially invalid due to dysfunctional CFR leading to potential undertreatment of CAD in these patients.CFR disturbance in AS mainly due to myocardial overload causing concentric hypertrophy, increased oxygen consumption and neurohormonal activation leading to increased vascular resistance. Current studies are investigating the validity of FFR and iFR in AS patients. Recent data demonstrate very good correlation between FFR and iFR derived values to PET myocardial perfusion imaging values in patients with no evidence of AS. Our study aims to investigate the diagnostic performance of FFR and iFR in intermediate-grade coronary stenosis in patients with severe aortic valve disease and correlate FFR- and iFR derived values with those extracted from PET-perfusion Imaging.
Interested in participating?
Request Info65 year and older
All sexes
Observational
Bad Oeynhausen, North Rhine-Westphalia, 32545, Germany
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 months
Evaluation of FFR-negative intermediary coronary stenoses in Patients with severe Aortic Stenosis Prior and 3 months following TAVI
Time frame: 3 months
Angina prevalence in patients with intermediate coronary Stenosis Prior to and 3 months following TAVI
Contact information is provided by the study sponsor or research team.
Astrid Kleemeyer
CONTACT
Tanja Rudolph, MD
CONTACT
Heart and Diabetes Center North-Rhine Westfalia
Other
Correlation of FFR and iFR With Cardiac PET Perfusion (at Rest and Under Adenosine) in the Evaluation of Intermediate Coronary Stenoses in Patients With Severe Aortic Valve Stenosis
Acronym: TAVI PET
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05487612
Aortic Valve Disease, Aortic Valve Stenosis
Toronto, Canada
View Trial DetailsNCT07016477
Aortic Valve Disease, Aortic Valve Stenosis
Charleston, South Carolina, United States
View Trial DetailsNCT04464655
Aortic Stenosis, Subvalvular, Aortic Valve Disease
Montreal, Quebec, Canada
View Trial DetailsNCT03470246
Aortic Valve Disease, Aortic Valve Stenosis
Kuopio, Finland
View Trial Details